EP2934510
LFA-1 INHIBITOR FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.12.2013EP published:
28.10.2020EP application number:
13865757.2
EPO information:
European Patent Register
Max expiry date:
17.12.2033
Title:
LFA-1 INHIBITOR FORMULATIONS
Timeline
Today
18.12.2013EP application
28.10.2020EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
NEWMAN, MaryAddress:
Brisbane, CA 94005, US
Name:
HUNKE, WilliamAddress:
Middletown, DE 19709, US
Priority
Number:
201261739609 PDate:
19.12.2012Country:
US
Number:
201361758147 PDate:
29.1.2013Country:
US
Classification
Categories:
A61K 31/343, A61K 9/00, A61K 47/02, A61K 31/4725, A61P 27/02